XRX
45
4
XRAY
28
-3
ACN
52
-2
DG
72
2
SE
43
3
HST
58
-4
RRC
59
-4
OI
50
-6
DOW
38
-2
ED
42
-3
EFX
52
3
KSS
54
2
MDT
53
-2
HRL
30
-5
COF
67
2
BAC
75
-3
AES
51
-4
EL
58
5
BEN
50
-3
CF
42
-6
XRX
45
4
XRAY
28
-3
ACN
52
-2
DG
72
2
SE
43
3
HST
58
-4
RRC
59
-4
OI
50
-6
DOW
38
-2
ED
42
-3
EFX
52
3
KSS
54
2
MDT
53
-2
HRL
30
-5
COF
67
2
BAC
75
-3
AES
51
-4
EL
58
5
BEN
50
-3
CF
42
-6
Financhill
Back

The New York Times Co. Vs. Nektar Therapeutics Industry Stock Comparison

Buy
83

NYT
The New York Times Co.

Last Price:
$69.50
Seasonality Move:
5.57%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.63
Seasonality Move:
11.58%
Buy
83
The New York Times Co. (NYT) is a Buy

Is The New York Times Co. a Buy, Sell or Hold?

  • The current The New York Times Co. [NYT] share price is $67.30. The Score for NYT is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
  • NYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NYT Stock Price Chart

What is The New York Times Co.'s stock price today?

  • The The New York Times Co. share price today is $67.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

NYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.76 Buy
Relative Strength Index (14 RSI): 71.49 Buy
Chaikin Money Flow: -839631 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.71 Buy
20-day SMA: 65.21 Buy
50-day SMA: 60.87 Buy
200-day SMA: 55.87 Buy
8-day EMA: 66.78 Buy
20-day EMA: 65.18 Buy
50-day EMA: 62.34 Buy
200-day EMA: 57.31 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

The New York Times Co. Earnings Growth & NYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.24 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

The New York Times Co. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):